Follow the people · Insider
Sharon Benzeno
Sharon Benzeno files insider transactions with the SEC as a chief commercial ofc imm med of Adaptive Biotechnologies (ADPT). We hold 3 disclosed purchases and sales filed since 18 February 2020, 2 of them in the last 90 days.
- Files forADPT
- Disclosed buys and sells3 in all, 2 in the last 90 days
- Last disclosure30 June 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 13 February 2020 — 29 June 2026Chief Commercial Ofc Imm Med · Adaptive Biotechnologies (ADPT)198 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 11,034 shares of Adaptive BiotechnologiesSEC Form 430 June 2026Common Stock · traded 26 June 2026 · filed 30 June 2026
- exercised options over 24,944 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 430 June 2026Stock Option (right to buy) · traded 29 June 2026 · filed 30 June 2026
- exercised options over 24,944 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 430 June 2026Stock Option (right to buy) · traded 29 June 2026 · filed 30 June 2026
- exercised options over 51,570 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 430 June 2026Stock Option (right to buy) · traded 29 June 2026 · filed 30 June 2026
- ▼ sold on the open market 11,034 shares of Adaptive BiotechnologiesSEC Form 430 June 2026Common Stock · traded 26 June 2026 · filed 30 June 2026
- exercised options over 1,837 shares of Adaptive BiotechnologiesSEC Form 430 June 2026Common Stock · traded 29 June 2026 · filed 30 June 2026
- exercised options over 24,944 shares of Adaptive BiotechnologiesSEC Form 430 June 2026Common Stock · traded 29 June 2026 · filed 30 June 2026
- exercised options over 24,944 shares of Adaptive BiotechnologiesSEC Form 430 June 2026Common Stock · traded 29 June 2026 · filed 30 June 2026
- exercised options over 51,570 shares of Adaptive BiotechnologiesSEC Form 430 June 2026Common Stock · traded 29 June 2026 · filed 30 June 2026
- ▼ sold on the open market 154,768 shares of Adaptive BiotechnologiesSEC Form 430 June 2026Common Stock · traded 29 June 2026 · filed 30 June 2026
- exercised options over 11,034 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 430 June 2026Stock Option (right to buy) · traded 26 June 2026 · filed 30 June 2026
- exercised options over 1,837 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 430 June 2026Stock Option (right to buy) · traded 29 June 2026 · filed 30 June 2026
- ▼ sold on the open market 63,103 shares of Adaptive BiotechnologiesSEC Form 413 March 2026Common Stock · traded 11 March 2026 · filed 13 March 2026
- ▼ sold on the open market 63,103 shares of Adaptive BiotechnologiesSEC Form 413 March 2026Common Stock · traded 11 March 2026 · filed 13 March 2026
- was granted 39,063 shares of Adaptive BiotechnologiesSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- was granted 39,063 shares of Adaptive BiotechnologiesSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- exercised options over 4,290 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 December 2025Stock Option (right to buy) · traded 4 December 2025 · filed 8 December 2025
- exercised options over 4,157 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 December 2025Stock Option (right to buy) · traded 4 December 2025 · filed 8 December 2025
- exercised options over 4,157 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 December 2025Stock Option (right to buy) · traded 4 December 2025 · filed 8 December 2025
- exercised options over 4,290 shares of Adaptive BiotechnologiesSEC Form 48 December 2025Common Stock · traded 4 December 2025 · filed 8 December 2025
- exercised options over 4,157 shares of Adaptive BiotechnologiesSEC Form 48 December 2025Common Stock · traded 4 December 2025 · filed 8 December 2025
- exercised options over 4,157 shares of Adaptive BiotechnologiesSEC Form 48 December 2025Common Stock · traded 4 December 2025 · filed 8 December 2025
- ▼ sold on the open market 12,604 shares of Adaptive BiotechnologiesSEC Form 48 December 2025Common Stock · traded 4 December 2025 · filed 8 December 2025
- exercised options over 133,032 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 424 November 2025Stock Option (right to buy) · traded 20 November 2025 · filed 24 November 2025
- exercised options over 68,961 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 424 November 2025Stock Option (right to buy) · traded 20 November 2025 · filed 24 November 2025
- exercised options over 834 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 424 November 2025Stock Option (right to buy) · traded 21 November 2025 · filed 24 November 2025
- exercised options over 20,834 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 424 November 2025Stock Option (right to buy) · traded 21 November 2025 · filed 24 November 2025
- exercised options over 49,480 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 424 November 2025Stock Option (right to buy) · traded 21 November 2025 · filed 24 November 2025
- exercised options over 34,375 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 424 November 2025Stock Option (right to buy) · traded 21 November 2025 · filed 24 November 2025
- exercised options over 119,809 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 424 November 2025Stock Option (right to buy) · traded 21 November 2025 · filed 24 November 2025
- exercised options over 83,145 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 424 November 2025Stock Option (right to buy) · traded 21 November 2025 · filed 24 November 2025
- exercised options over 133,032 shares of Adaptive BiotechnologiesSEC Form 424 November 2025Common Stock · traded 20 November 2025 · filed 24 November 2025
- exercised options over 68,961 shares of Adaptive BiotechnologiesSEC Form 424 November 2025Common Stock · traded 20 November 2025 · filed 24 November 2025
- ▼ sold on the open market 297,925 shares of Adaptive BiotechnologiesSEC Form 424 November 2025Common Stock · traded 20 November 2025 · filed 24 November 2025
- exercised options over 834 shares of Adaptive BiotechnologiesSEC Form 424 November 2025Common Stock · traded 21 November 2025 · filed 24 November 2025
- exercised options over 20,834 shares of Adaptive BiotechnologiesSEC Form 424 November 2025Common Stock · traded 21 November 2025 · filed 24 November 2025
- exercised options over 49,480 shares of Adaptive BiotechnologiesSEC Form 424 November 2025Common Stock · traded 21 November 2025 · filed 24 November 2025
- exercised options over 34,375 shares of Adaptive BiotechnologiesSEC Form 424 November 2025Common Stock · traded 21 November 2025 · filed 24 November 2025
- exercised options over 119,809 shares of Adaptive BiotechnologiesSEC Form 424 November 2025Common Stock · traded 21 November 2025 · filed 24 November 2025
- exercised options over 83,145 shares of Adaptive BiotechnologiesSEC Form 424 November 2025Common Stock · traded 21 November 2025 · filed 24 November 2025
- ▼ sold on the open market 308,477 shares of Adaptive BiotechnologiesSEC Form 424 November 2025Common Stock · traded 21 November 2025 · filed 24 November 2025
- was granted 165,027 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 March 2025Stock Option (right to buy) · traded 4 March 2025 · filed 6 March 2025
- was granted 109,973 shares of Adaptive BiotechnologiesSEC Form 46 March 2025Common Stock · traded 4 March 2025 · filed 6 March 2025
- ▼ sold on the open market 41,600 shares of Adaptive BiotechnologiesSEC Form 46 March 2025Common Stock · traded 5 March 2025 · filed 6 March 2025
- ▼ sold on the open market 3,065 shares of Adaptive BiotechnologiesSEC Form 46 March 2025Common Stock · traded 5 March 2025 · filed 6 March 2025
- was granted 199,549 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 March 2024Stock Option (right to buy) · traded 4 March 2024 · filed 6 March 2024
- was granted 132,979 shares of Adaptive BiotechnologiesSEC Form 46 March 2024Common Stock · traded 4 March 2024 · filed 6 March 2024
- ▼ sold on the open market 10,746 shares of Adaptive BiotechnologiesSEC Form 46 March 2024Common Stock · traded 5 March 2024 · filed 6 March 2024
- ▼ sold on the open market 18,644 shares of Adaptive BiotechnologiesSEC Form 46 March 2024Common Stock · traded 5 March 2024 · filed 6 March 2024
- was granted 199,549 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 March 2023Stock Option (right to buy) · traded 6 March 2023 · filed 8 March 2023
- was granted 132,979 shares of Adaptive BiotechnologiesSEC Form 48 March 2023Common Stock · traded 6 March 2023 · filed 8 March 2023
- ▼ sold on the open market 11,749 shares of Adaptive BiotechnologiesSEC Form 48 March 2023Common Stock · traded 6 March 2023 · filed 8 March 2023
- was granted 205,931 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 March 2022Stock Option (Right to Buy) · traded 4 March 2022 · filed 8 March 2022
- was granted 82,372 shares of Adaptive BiotechnologiesSEC Form 48 March 2022Common Stock · traded 4 March 2022 · filed 8 March 2022
- ▼ sold on the open market 2,670 shares of Adaptive BiotechnologiesSEC Form 48 March 2022Common Stock · traded 7 March 2022 · filed 8 March 2022
- exercised options over 1,354 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 March 2021Stock Option (Right to Buy) · traded 15 March 2021 · filed 17 March 2021
- exercised options over 1,354 shares of Adaptive BiotechnologiesSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- ▼ sold on the open market 340 shares of Adaptive BiotechnologiesSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- ▼ sold on the open market 1,014 shares of Adaptive BiotechnologiesSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- was granted 22,894 shares of Adaptive BiotechnologiesSEC Form 48 March 2021Common Stock · traded 4 March 2021 · filed 8 March 2021
- was granted 57,234 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 March 2021Stock Option (Right to Buy) · traded 4 March 2021 · filed 8 March 2021
- exercised options over 2,604 shares of Adaptive BiotechnologiesSEC Form 43 March 2021Common Stock · traded 1 March 2021 · filed 3 March 2021
- exercised options over 2,604 shares of Adaptive BiotechnologiesSEC Form 43 March 2021Common Stock · traded 1 March 2021 · filed 3 March 2021
- exercised options over 1,563 shares of Adaptive BiotechnologiesSEC Form 43 March 2021Common Stock · traded 1 March 2021 · filed 3 March 2021
- ▼ sold on the open market 6,210 shares of Adaptive BiotechnologiesSEC Form 43 March 2021Common Stock · traded 1 March 2021 · filed 3 March 2021
- ▼ sold on the open market 561 shares of Adaptive BiotechnologiesSEC Form 43 March 2021Common Stock · traded 1 March 2021 · filed 3 March 2021
- exercised options over 2,604 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 43 March 2021Stock Option (Right to Buy) · traded 1 March 2021 · filed 3 March 2021
- exercised options over 2,604 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 43 March 2021Stock Option (Right to Buy) · traded 1 March 2021 · filed 3 March 2021
- exercised options over 1,563 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 43 March 2021Stock Option (Right to Buy) · traded 1 March 2021 · filed 3 March 2021
- exercised options over 416 shares of Adaptive BiotechnologiesSEC Form 43 March 2021Common Stock · traded 19 February 2021 · filed 3 March 2021
- ▼ sold on the open market 416 shares of Adaptive BiotechnologiesSEC Form 43 March 2021Common Stock · traded 19 February 2021 · filed 3 March 2021
- exercised options over 416 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 43 March 2021Stock Option (Right to Buy) · traded 19 February 2021 · filed 3 March 2021
- exercised options over 16,250 shares of Adaptive BiotechnologiesSEC Form 417 February 2021Common Stock · traded 16 February 2021 · filed 17 February 2021
- ▼ sold on the open market 5,022 shares of Adaptive BiotechnologiesSEC Form 417 February 2021Common Stock · traded 16 February 2021 · filed 17 February 2021
- ▼ sold on the open market 1,700 shares of Adaptive BiotechnologiesSEC Form 417 February 2021Common Stock · traded 16 February 2021 · filed 17 February 2021
- ▼ sold on the open market 9,528 shares of Adaptive BiotechnologiesSEC Form 417 February 2021Common Stock · traded 16 February 2021 · filed 17 February 2021
- exercised options over 16,250 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 February 2021Stock Option (Right to Buy) · traded 16 February 2021 · filed 17 February 2021
- exercised options over 2,604 shares of Adaptive BiotechnologiesSEC Form 43 February 2021Common Stock · traded 1 February 2021 · filed 3 February 2021
- exercised options over 2,604 shares of Adaptive BiotechnologiesSEC Form 43 February 2021Common Stock · traded 1 February 2021 · filed 3 February 2021
- exercised options over 1,562 shares of Adaptive BiotechnologiesSEC Form 43 February 2021Common Stock · traded 1 February 2021 · filed 3 February 2021
- ▼ sold on the open market 6,470 shares of Adaptive BiotechnologiesSEC Form 43 February 2021Common Stock · traded 1 February 2021 · filed 3 February 2021
- ▼ sold on the open market 300 shares of Adaptive BiotechnologiesSEC Form 43 February 2021Common Stock · traded 1 February 2021 · filed 3 February 2021
- exercised options over 2,604 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 43 February 2021Stock Option (Right to Buy) · traded 1 February 2021 · filed 3 February 2021
- exercised options over 2,604 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 43 February 2021Stock Option (Right to Buy) · traded 1 February 2021 · filed 3 February 2021
- exercised options over 1,562 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 43 February 2021Stock Option (Right to Buy) · traded 1 February 2021 · filed 3 February 2021
- exercised options over 417 shares of Adaptive BiotechnologiesSEC Form 420 January 2021Common Stock · traded 19 January 2021 · filed 20 January 2021
- ▼ sold on the open market 417 shares of Adaptive BiotechnologiesSEC Form 420 January 2021Common Stock · traded 19 January 2021 · filed 20 January 2021
- exercised options over 417 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 420 January 2021Stock Option (Right to Buy) · traded 19 January 2021 · filed 20 January 2021
- exercised options over 2,604 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 January 2021Stock Option (Right to Buy) · traded 4 January 2021 · filed 6 January 2021
- exercised options over 2,604 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 January 2021Stock Option (Right to Buy) · traded 4 January 2021 · filed 6 January 2021
- exercised options over 1,563 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 January 2021Common Stock (Right to Buy) · traded 4 January 2021 · filed 6 January 2021
- exercised options over 2,604 shares of Adaptive BiotechnologiesSEC Form 46 January 2021Common Stock · traded 4 January 2021 · filed 6 January 2021
- exercised options over 2,604 shares of Adaptive BiotechnologiesSEC Form 46 January 2021Common Stock · traded 4 January 2021 · filed 6 January 2021
- exercised options over 1,563 shares of Adaptive BiotechnologiesSEC Form 46 January 2021Common Stock · traded 4 January 2021 · filed 6 January 2021
- ▼ sold on the open market 2,209 shares of Adaptive BiotechnologiesSEC Form 46 January 2021Common Stock · traded 4 January 2021 · filed 6 January 2021
- ▼ sold on the open market 3,800 shares of Adaptive BiotechnologiesSEC Form 46 January 2021Common Stock · traded 4 January 2021 · filed 6 January 2021
- ▼ sold on the open market 495 shares of Adaptive BiotechnologiesSEC Form 46 January 2021Common Stock · traded 4 January 2021 · filed 6 January 2021
- ▼ sold on the open market 267 shares of Adaptive BiotechnologiesSEC Form 46 January 2021Common Stock · traded 4 January 2021 · filed 6 January 2021
- exercised options over 417 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 423 December 2020Stock Option (Right to Buy) · traded 21 December 2020 · filed 23 December 2020
- exercised options over 417 shares of Adaptive BiotechnologiesSEC Form 423 December 2020Common Stock · traded 21 December 2020 · filed 23 December 2020
- ▼ sold on the open market 417 shares of Adaptive BiotechnologiesSEC Form 423 December 2020Common Stock · traded 21 December 2020 · filed 23 December 2020
- exercised options over 2,604 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 42 December 2020Stock Option (Right to Buy) · traded 1 December 2020 · filed 2 December 2020
- exercised options over 2,604 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 42 December 2020Stock Option (Right to Buy) · traded 1 December 2020 · filed 2 December 2020
- exercised options over 1,562 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 42 December 2020Common Stock (Right to Buy) · traded 1 December 2020 · filed 2 December 2020
- exercised options over 2,604 shares of Adaptive BiotechnologiesSEC Form 42 December 2020Common Stock · traded 1 December 2020 · filed 2 December 2020
- exercised options over 2,604 shares of Adaptive BiotechnologiesSEC Form 42 December 2020Common Stock · traded 1 December 2020 · filed 2 December 2020
- exercised options over 1,562 shares of Adaptive BiotechnologiesSEC Form 42 December 2020Common Stock · traded 1 December 2020 · filed 2 December 2020
- ▼ sold on the open market 3,077 shares of Adaptive BiotechnologiesSEC Form 42 December 2020Common Stock · traded 1 December 2020 · filed 2 December 2020
- ▼ sold on the open market 3,693 shares of Adaptive BiotechnologiesSEC Form 42 December 2020Common Stock · traded 1 December 2020 · filed 2 December 2020
- exercised options over 416 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 423 November 2020Stock Option (Right to Buy) · traded 19 November 2020 · filed 23 November 2020
- exercised options over 416 shares of Adaptive BiotechnologiesSEC Form 423 November 2020Common Stock · traded 19 November 2020 · filed 23 November 2020
- ▼ sold on the open market 416 shares of Adaptive BiotechnologiesSEC Form 423 November 2020Common Stock · traded 19 November 2020 · filed 23 November 2020
- exercised options over 2,605 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 44 November 2020Stock Option (Right to Buy) · traded 2 November 2020 · filed 4 November 2020
- exercised options over 2,604 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 44 November 2020Stock Option (Right to Buy) · traded 2 November 2020 · filed 4 November 2020
- exercised options over 1,563 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 44 November 2020Common Stock (Right to Buy) · traded 2 November 2020 · filed 4 November 2020
- exercised options over 2,605 shares of Adaptive BiotechnologiesSEC Form 44 November 2020Common Stock · traded 2 November 2020 · filed 4 November 2020
- exercised options over 2,604 shares of Adaptive BiotechnologiesSEC Form 44 November 2020Common Stock · traded 2 November 2020 · filed 4 November 2020
- exercised options over 1,563 shares of Adaptive BiotechnologiesSEC Form 44 November 2020Common Stock · traded 2 November 2020 · filed 4 November 2020
- ▼ sold on the open market 5,698 shares of Adaptive BiotechnologiesSEC Form 44 November 2020Common Stock · traded 2 November 2020 · filed 4 November 2020
- ▼ sold on the open market 1,074 shares of Adaptive BiotechnologiesSEC Form 44 November 2020Common Stock · traded 2 November 2020 · filed 4 November 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.